Evaluation of Fluid Biomarkers Around Implants Exhibiting Early Stage Periimplant Bone Loss
2026. május 7. frissítette: Raziye Tugce Can Keles, Pamukkale University
Evaluation of Biomarkers Involved In Bone Metabolism (Remodeling) In Periimplanter Crevicular Fluid of Implants With Early Marginal Bone Loss: A Retrospective Clinical Study
This study aimed to compare biological mediators known to be important in peri-implant diseases in implants with and without early stage marginal bone loss.
A total of 118 implants in 59 patients were designated as test and control groups.
The radiographic and periodontal data of the included implants, along with peri-implant sulcus fluid samples, were evaluated.
A tanulmány áttekintése
Állapot
Befejezve
Körülmények
Részletes leírás
This study included clinical and radiographic records of patients who received implant treatment in the maxilla and/or mandible between 11/2021 and 9/2024.
Patients were divided into test and control groups based on the presence/absence of EMBL after prosthetic loading.
Periodontal clinical measurements were recorded and peri-implant sulcus fluid (PISF) samples were collected.
Sclerostin, calprotectin, type I collagen cross-linked N-telopeptide (NTx), matrix metalloproteinase (MMP)-8, and MMP-9 levels were analyzed using ELISA.
Group comparisons were performed with the statistical analyses.
Tanulmány típusa
Megfigyelő
Beiratkozás (Tényleges)
59
Kapcsolatok és helyek
Ez a rész a vizsgálatot végzők elérhetőségeit, valamint a vizsgálat lefolytatásának helyére vonatkozó információkat tartalmazza.
Tanulmányi helyek
-
-
-
Denizli, Törökország (Türkiye), 20160
- Pamukkale University, Faculty of Dentistry, Periodontology
-
-
Részvételi kritériumok
A kutatók olyan embereket keresnek, akik megfelelnek egy bizonyos leírásnak, az úgynevezett jogosultsági kritériumoknak. Néhány példa ezekre a kritériumokra a személy általános egészségi állapota vagy a korábbi kezelések.
Jogosultsági kritériumok
Tanulmányozható életkorok
- Gyermek
- Felnőtt
- Idősebb felnőtt
Egészséges önkénteseket fogad
Igen
Mintavételi módszer
Nem valószínűségi minta
Tanulmányi populáció
Patients who received implant treatment at the Department of Periodontology, Pamukkale University Faculty of Dentistry.
Leírás
Inclusion Criteria:
- Presence of 1 mm or more of radiographic marginal bone loss within the first 3 months after implant placement
- Availability of radiographic documentation
- Availability of demographic data, surgical records, and data related to the implant used
- Physical condition classified as Class I and II according to the American Society of Anesthesiologists (ASA) classification
- Patients with no smoking history in the last 10 years
- Fixed implant-supported restorations
- Screw-retained implants
Exclusion Criteria:
- Patients receiving and/or maintaining implant treatment at centers other than the Department of Periodontology, Pamukkale University Faculty of Dentistry
- Patients with incomplete or unreachable files or radiographic documentation
- Patients with a known systemic disease/condition that alters their physical condition or bone metabolism
- Severe bruxism cases
- Pregnant and breastfeeding patients
- Patients with incomplete implant-supported prosthesis
- Areas grafted during or before implant surgery
- Removable implant-supported restorations
- Cement-retained implants
- Patients undergoing peri-implantitis treatment
Tanulási terv
Ez a rész a vizsgálati terv részleteit tartalmazza, beleértve a vizsgálat megtervezését és a vizsgálat mérését.
Hogyan készül a tanulmány?
Tervezési részletek
Kohorszok és beavatkozások
Csoport / Kohorsz |
Beavatkozás / kezelés |
|---|---|
|
Test
Presence of marginal bone loss of 1 mm or more within the first 3 months after implant placement
|
To evaluate biomarkers associated with peri-implant bone loss, periopaper was placed in the peri-implant pocket and absorbed with sulcus fluid.
Parallel cone technique was used during periapical imaging to accurately measure peri-implant bone loss.
|
|
Control
Presence of less than 1 mm of marginal bone loss within the first 3 months after implant placement
|
To evaluate biomarkers associated with peri-implant bone loss, periopaper was placed in the peri-implant pocket and absorbed with sulcus fluid.
Parallel cone technique was used during periapical imaging to accurately measure peri-implant bone loss.
|
Mit mér a tanulmány?
Elsődleges eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Calprotectin levels in peri-implant crevicular fluid
Időkeret: 6-8 week after prosthetic treatment
|
After collecting peri-implant sulcus fluid using the paper strip method, calprotectin levels in the peri-implant sulcus region were determined using the ELISA method and recorded in ng/ml.
|
6-8 week after prosthetic treatment
|
|
Sclerostin levels in peri-implant crevicular fluid
Időkeret: 6-8 week after prosthetic treatment
|
After collecting peri-implant sulcus fluid using the paper strip method, sclerostin levels in the peri-implant sulcus region were determined using the ELISA method and recorded in pg/ml.
|
6-8 week after prosthetic treatment
|
|
NTx levels in peri-implant crevicular fluid
Időkeret: 6-8 week after prosthetic treatment
|
After collecting peri-implant sulcus fluid using the paper strip method, NTx levels in the peri-implant sulcus region were determined using the ELISA method and recorded in ng/ml.
|
6-8 week after prosthetic treatment
|
|
MMP-8 levels in peri-implant crevicular fluid
Időkeret: 6-8 week after prosthetic treatment
|
After collecting peri-implant sulcus fluid using the paper strip method, MMP-8 levels in the peri-implant sulcus region were determined using the ELISA method and recorded in ng/ml.
|
6-8 week after prosthetic treatment
|
|
MMP-9 levels in peri-implant crevicular fluid
Időkeret: 6-8 week after prosthetic treatment
|
After collecting peri-implant sulcus fluid using the paper strip method, MMP-9 levels in the peri-implant sulcus region were determined using the ELISA method and recorded in ng/ml.
|
6-8 week after prosthetic treatment
|
Egyéb eredményintézkedések
Eredménymérő |
Intézkedés leírása |
Időkeret |
|---|---|---|
|
Radiographic detecting of Peri-implant marginal bone loss
Időkeret: Baseline, 3 months
|
The amount of marginal bone loss was determined by comparing the periapical radiograph taken on the day the implants were placed with the radiograph taken at 3 months.
Measurements of digital radiographic images were performed using computer software.
Then, study groups were determined according to the presence or absence of peri-implant marginal bone loss.
|
Baseline, 3 months
|
|
Modified Bleeding İndex
Időkeret: During the same session as the peri-implant fluid collection procedure
|
This assessment was performed based on the bleeding response following gentle probing with a plastic probe in the four regions of each implant (mesial, distal, palatal/lingual, and buccal).
The severity of bleeding observed within approximately 10-30 seconds after probing was scored and recorded.
The scoring system was graded as follows: 0: no bleeding, 1: bleeding at a single point, 2: bleeding at several points or in a linear pattern, 3: heavy bleeding following probing.
|
During the same session as the peri-implant fluid collection procedure
|
|
Peri-implant pocket depth
Időkeret: During the same session as the peri-implant fluid collection procedure
|
A plastic periodontal probe was used to determine peri-implant pocket depth.
Measurements were taken by using the probe, supported by its own weight, parallel to the long axis of the tooth.
Pocket depth was measured at 6 sites (mesio-buccal, buccal, disto-buccal, mesio-palatal/lingual, palatal/lingual, disto-palatal/lingual) for each implant included in the study and recorded in millimeters (mm).
The pocket depth value for each dental implant was obtained by calculating the average of the 6 measured values.
|
During the same session as the peri-implant fluid collection procedure
|
|
Gingival İndex
Időkeret: During the same session as the peri-implant fluid collection procedure
|
The mesial, distal, buccal, and lingual/palatal surfaces of each tooth/implant were evaluated separately, and the average of the scores obtained was recorded as the gingival index value for that tooth/implant.
Scoring during the evaluation was performed as follows: 0 = normal gingiva, 1 = mild inflammation (color change, mild edema, no bleeding on probing), 2 = moderate inflammation (redness, edema, bleeding on probing), 3 = severe inflammation (marked redness, edema, ulceration, spontaneous bleeding).
Subsequently, all values were summed and divided by the total number of teeth and implants to record the gingival index score.
|
During the same session as the peri-implant fluid collection procedure
|
|
Modified Plaque İndex
Időkeret: During the same session as the peri-implant fluid collection procedure
|
The mesial, distal, buccal, and lingual/palatal surfaces around the teeth/implants were examined, and the average of the scores obtained for each surface was recorded as the plaque index for that tooth/implant.
The scoring criteria were as follows: 0 = no plaque, 1 = plaque detectable only with a probe, 2 = soft plaque accumulation visible to the naked eye, 3 = the tooth surface covered with a distinct plaque layer.
Subsequently, all values were summed and divided by the total number of teeth and implants to record the modified plaque index score.
|
During the same session as the peri-implant fluid collection procedure
|
|
Peri-implant mucosal recession
Időkeret: During the same session as the peri-implant fluid collection procedure
|
The abutment-implant interface was designated as the reference point for determining the extent of peri-implant mucosal recession, and the distance between the reference point and the free gingival margin was measured using a periodontal probe.
Mucosal recession was recorded in four regions (mesio-buccal, mid-buccal, disto-buccal, mid-lingual/palatal) for each implant included in the study.
The recession value for each implant was obtained by calculating the average of the four measured values.
|
During the same session as the peri-implant fluid collection procedure
|
Együttműködők és nyomozók
Itt találhatja meg a tanulmányban érintett személyeket és szervezeteket.
Szponzor
Nyomozók
- Kutatásvezető: Raziye Tugce Can Keles, R.A., Pamukkale University Faculty of Dentistry, Department of Periodontology
- Tanulmányi igazgató: Gizem Torumtay Cin, Assoc. Prof., Pamukkale University Faculty of Dentistry, Department of Periodontology
Tanulmányi rekorddátumok
Ezek a dátumok nyomon követik a ClinicalTrials.gov webhelyre benyújtott vizsgálati rekordok és összefoglaló eredmények benyújtásának folyamatát. A vizsgálati feljegyzéseket és a jelentett eredményeket a Nemzeti Orvostudományi Könyvtár (NLM) felülvizsgálja, hogy megbizonyosodjon arról, hogy megfelelnek-e az adott minőség-ellenőrzési szabványoknak, mielőtt közzéteszik őket a nyilvános weboldalon.
Tanulmány főbb dátumok
Tanulmány kezdete (Tényleges)
2025. március 6.
Elsődleges befejezés (Tényleges)
2025. szeptember 6.
A tanulmány befejezése (Tényleges)
2025. szeptember 6.
Tanulmányi regisztráció dátumai
Először benyújtva
2026. május 3.
Először nyújtották be, amely megfelel a minőségbiztosítási kritériumoknak
2026. május 7.
Első közzététel (Tényleges)
2026. május 13.
Tanulmányi rekordok frissítései
Utolsó frissítés közzétéve (Tényleges)
2026. május 13.
Az utolsó frissítés elküldve, amely megfelel a minőségbiztosítási kritériumoknak
2026. május 7.
Utolsó ellenőrzés
2026. május 1.
Több információ
A tanulmányhoz kapcsolódó kifejezések
Kulcsszavak
További vonatkozó MeSH feltételek
Egyéb vizsgálati azonosító számok
- E-60116787-020-604271
- 2025DİŞF001 (Egyéb azonosító: Office of Scientific Research Projects of Pamukkale University)
Terv az egyéni résztvevői adatokhoz (IPD)
Tervezi megosztani az egyéni résztvevői adatokat (IPD)?
NEM
Gyógyszer- és eszközinformációk, tanulmányi dokumentumok
Egy amerikai FDA által szabályozott gyógyszerkészítményt tanulmányoz
Nem
Egy amerikai FDA által szabályozott eszközterméket tanulmányoz
Nem
Ezt az információt közvetlenül a clinicaltrials.gov webhelyről szereztük be, változtatás nélkül. Ha bármilyen kérése van vizsgálati adatainak módosítására, eltávolítására vagy frissítésére, kérjük, írjon a következő címre: register@clinicaltrials.gov. Amint a változás bevezetésre kerül a clinicaltrials.gov oldalon, ez a webhelyünkön is automatikusan frissül. .